Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2015, Article ID 408574, 5 pages
http://dx.doi.org/10.1155/2015/408574
Review Article

Implications of Renal Denervation Therapy in Patients with Sleep Apnea

Cardiovascular Risk Unit, Department of Internal Medicine, University Hospital Complex City of Granada, Avenida Fuerzas Armadas 2, 18014 Granada, Spain

Received 15 November 2014; Accepted 8 February 2015

Academic Editor: Samy I. McFarlane

Copyright © 2015 Fernando Jaén-Águila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Guilleminault, A. Tilkian, and W. C. Dement, “Sleep apnea syndromes,” Annual Review of Medicine, vol. 27, pp. 465–485, 1976. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Durán-Cantolla, F. J. Puertas-Cuesta, G. Pin-Arboledas, and J. S. María-Cano, “National consensus document about sleep apnea—Hypopnea syndrome,” Archivos de Bronconeumología, vol. 41, pp. 1–110, 2005. View at Google Scholar
  3. J.-P. Baguet, G. Barone-Rochette, and J.-L. Pépin, “Hypertension and obstructive sleep apnoea syndrome: current perspectives,” Journal of Human Hypertension, vol. 23, no. 7, pp. 431–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. Peppard, T. Young, M. Palta, and J. Skatrud, “Prospective study of the association between sleep-disordered breathing and hypertension,” The New England Journal of Medicine, vol. 342, no. 19, pp. 1378–1384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. Logan, S. M. Perlikowski, A. Mente et al., “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension,” Journal of Hypertension, vol. 19, no. 12, pp. 2271–2277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. V. K. Somers, D. P. White, R. Amin et al., “Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health),” Circulation, vol. 118, no. 10, pp. 1080–1111, 2008. View at Publisher · View at Google Scholar
  7. H. K. Yaggi, J. Concato, W. N. Kernan, J. H. Lichtman, L. M. Brass, and V. Mohsenin, “Obstructive sleep apnea as a risk factor for stroke and death,” The New England Journal of Medicine, vol. 353, no. 19, pp. 2034–2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. T. Pepperell, S. Ramdassingh-Dow, N. Crosthwaite et al., “Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial,” The Lancet, vol. 359, no. 9302, pp. 204–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. C. Gonsalves, D. Martínez, and M. Gus, “Obstructive sleep apnea and resistant hypertension: a case control study,” Chest, vol. 131, no. 2, pp. 453–459, 2007. View at Google Scholar
  10. S. L. Daugherty, J. D. Powers, D. J. Magid et al., “Incidence and prognosis of resistant hypertension in hypertensive patients,” Circulation, vol. 125, no. 13, pp. 1635–1642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kartali, E. Daskalopoulou, P. Geleris et al., “The effect of continuous positive airway pressure therapy on blood pressure and arterial stiffness in hypertensive patients with obstructive sleep apnea,” Sleep and Breathing, vol. 18, no. 3, pp. 635–640, 2014. View at Publisher · View at Google Scholar
  12. C. Tsioufis, A. Kasiakogias, C. Thomopoulos, A. Manolis, and C. Stefanadis, “Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy,” Journal of Hypertension, vol. 28, no. 5, pp. 875–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Mancia, R. Fagard, K. Narkiewicz et al., “2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 34, pp. 2159–2219, 2013. View at Publisher · View at Google Scholar
  14. S. Isono, J. E. Remmers, A. Tanaka, Y. Sho, J. Sato, and T. Nishino, “Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects,” Journal of Applied Physiology, vol. 82, no. 4, pp. 1319–1326, 1997. View at Google Scholar · View at Scopus
  15. W. S. Mezzanotte, D. J. Tangel, and D. P. White, “Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism),” The Journal of Clinical Investigation, vol. 89, no. 5, pp. 1571–1579, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. V. K. Somers, M. E. Dyken, M. P. Clary, and F. M. Abboud, “Sympathetic neural mechanisms in obstructive sleep apnea,” The Journal of Clinical Investigation, vol. 96, no. 4, pp. 1897–1904, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Narkiewicz, P. J. H. van de Borne, N. Montano, M. E. Dyken, B. G. Phillips, and V. K. Somers, “Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea,” Circulation, vol. 97, no. 10, pp. 943–945, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. K. K. Gaddam, M. K. Nishizaka, M. N. Pratt-Ubunama et al., “Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion,” Archives of Internal Medicine, vol. 168, no. 11, pp. 1159–1164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Schwab, K. B. Gupta, W. B. Gefter, L. J. Metzger, E. A. Hoffman, and A. I. Pack, “Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing: significance of the lateral pharyngeal walls,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 5, pp. 1673–1689, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. W. D. Hall, “Risk reduction associated with lowering systolic blood pressure: review of clinical trial data,” The American Heart Journal, vol. 138, no. 3, pp. S225–S230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Grassi, B. M. Cattaneo, G. Seravalle, A. Lanfranchi, and G. Mancia, “Baroreflex control of sympathetic nerve activity in essential and secondary hypertension,” Hypertension, vol. 31, no. 1, pp. 68–72, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Hedner, I. Wilcox, L. Laks, R. R. Grunstein, and C. E. Sullivan, “A specific and potent pressor effect of hypoxia in patients with sleep apnea,” The American Review of Respiratory Disease, vol. 146, no. 5, pp. 1240–1245, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Schulz, D. Schmidt, A. Blum et al., “Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy,” Thorax, vol. 55, no. 12, pp. 1046–1051, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. S. Shantha and S. B. Pancholy, “Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis,” Sleep and Breathing, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Damascelli, G. Patelli, V. Tichá et al., “Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension,” Journal of Vascular and Interventional Radiology, vol. 24, no. 5, pp. 632–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Schmiedel, A. Traenkner, N. Schmiedehausen, R. H. Strasser, and H. Schroetter, “The failing effects of renal sympathetic denervation in patients with drug resistant hypertension and untreated obstructive sleep apnea,” European Heart Journal, vol. 34, pp. 823–824, 2013. View at Google Scholar
  27. D. Thakur, N. Zimmerman, H. Rajebi, and M. R. Rajebi, “Renal sympathetic denervation and resistant hypertension,” Journal of Vascular and Interventional Radiology, vol. 24, pp. 145.e6–145.e7, 2013. View at Google Scholar
  28. A. Witkowski, A. Prejbisz, E. Florczak et al., “Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea,” Hypertension, vol. 58, no. 4, pp. 559–565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M.-M. Zhao, X.-X. Tan, N. Ding, and X.-L. Zhang, “Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension,” Zhonghua Yi Xue Za Zhi, vol. 93, no. 16, pp. 1234–1237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Mahfoud, T. F. Lüscher, B. Andersson et al., “Expert consensus document from the European Society of Cardiology on catheter-based renal denervation,” European Herat Journal, vol. 34, no. 28, pp. 2149–2157, 2013. View at Publisher · View at Google Scholar
  31. H. Krum, M. Schlaich, R. Whitbourn et al., “Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study,” The Lancet, vol. 373, no. 9671, pp. 1275–1281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. D. Esler, H. Krum, P. A. Sobotka, M. P. Schlaich, R. E. Schmieder, and M. Böhm, “Renal sympathetic denervation in patients with treatment-resistant hypertension (the SYMPLICITY HTN-2 Trial): a randomised controlled trial,” The Lancet, vol. 376, pp. 1903–1909, 2010. View at Publisher · View at Google Scholar
  33. D. L. Bhatt, D. E. Kandzari, W. W. O'Neill et al., “A controlled trial of renal denervation for resistant hypertension,” The New England Journal of Medicine, vol. 370, no. 15, pp. 1393–1401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Linz, F. Mahfoud, U. Schotten et al., “Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep-apnea,” Hypertension, vol. 60, no. 1, pp. 172–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. C. E. Sullivan, F. G. Issa, M. Berthon-Jones, and L. Eves, “Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares,” The Lancet, vol. 1, no. 8225, pp. 862–865, 1981. View at Google Scholar · View at Scopus
  36. E. Ballester, J. R. Badia, L. Hernández et al., “Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome,” The American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 2, pp. 495–501, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. S. B. Montesi, B. A. Edwards, A. Malhotra, and J. P. Bakker, “Effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials,” Journal of Clinical Sleep Medicine, vol. 8, no. 5, pp. 587–596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. G. E. Foster, P. J. Hanly, S. B. Ahmed, A. E. Beaudin, V. Pialoux, and M. J. Poulin, “Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism,” Hypertension, vol. 56, no. 3, pp. 369–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. W. D. Hall, “Risk reduction associated with lowering systolic blood pressure: review of clinical trial data,” American Heart Journal, vol. 138, no. 3, pp. S225–S230, 1999. View at Publisher · View at Google Scholar · View at Scopus